| Pharmaceutical Information |
| Drug Name |
Bromfenac sodium |
| Drug ID |
BADD_D00301 |
| Description |
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool to optimize surgical outcomes. |
| Indications and Usage |
For the treatment of postoperative inflammation in patients who have undergone cataract extraction. |
| Marketing Status |
approved |
| ATC Code |
S01BC11 |
| DrugBank ID |
DB00963
|
| KEGG ID |
D03163
|
| MeSH ID |
C053083
|
| PubChem ID |
23693301
|
| TTD Drug ID |
D0U1OM
|
| NDC Product Code |
24208-602; 14445-008; 12817-990; 42973-144; 71052-021; 46144-310; 50384-0150 |
| UNII |
8ECV571Y37
|
| Synonyms |
bromfenac | ISV-303 | Duract | sodium bromfenac | bromfenac sodium | Xibrom | AHR-10282 |
|
| Chemical Information |
| Molecular Formula |
C15H11BrNNaO3 |
| CAS Registry Number |
91714-93-1 |
| SMILES |
C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)[O-].[Na+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
